Stocks making the biggest moves midday: Five Below, Broadcom, Blackstone, UnitedHealth & more

Midday trading was driven by a sharp dispersion in single-name moves: Broadcom fell nearly 15% after Q2 revenue of $22.19B missed the $22.27B estimate, while Five Below dropped 13% and PVH plunged 20% on results/guidance reactions. On the upside, Alnylam rose 4% after announcing a strategic AI collaboration valued at up to $2B, Blackstone jumped 8% despite private credit withdrawal limits, and UnitedHealth and Medtronic gained 5% and 4% on analyst upgrades. Semiconductor peers weakened in sympathy, with Micron down almost 7%, AMD down 4%, and Arm down almost 5%.

Analysis

The biggest signal here is not the day-to-day stock moves but the widening dispersion between companies with credible long-duration growth and those whose guidance implies valuation is already doing too much of the work. AI-linked winners are now bifurcating: platform enablers with recurring monetization and clear utility are being rewarded, while pure inference-exposed semis are being punished whenever the market senses that 2025-2026 demand expectations have outrun near-term execution. That dynamic should pressure the whole AI capex complex for several sessions, especially names with crowded ownership and high forward multiples.

Health care is showing a different second-order effect: insurers and managed-care names are reacting to improving cost optics, which can become self-reinforcing if one or two quarters confirm margin stabilization. That matters because the market has been positioned for a prolonged medical-cost surge; any evidence that utilization normalizes tends to compress the perceived downside tail quickly, even if the fundamental improvement is incremental. In biotech, strategic AI partnerships are likely to command a scarcity premium, but the real winner may be the partner that can demonstrate cycle-time reduction rather than headline deal value.

Private credit and alternative managers are likely seeing an overreaction to redemption headlines. If withdrawal gating becomes a recurring theme, it could actually reinforce the franchise moat for the largest managers by discouraging retail-style inflows and pushing capital toward institutional vehicles with tighter terms. Meanwhile, discretionary retail remains fragile: the market is rewarding guidance quality over reported beats, which is a warning sign for any name relying on holiday-season elasticity or margin leverage to rescue growth.

Key Decisions for Investors

• Fade the broad AI semis pullback with a tactical basket long in AVGO/MU against short AMD/INTC over 2-4 weeks; use tighter stops because the first catalyst for reversal will be any follow-on AI demand confirmation.
• Sell short-dated downside in CRWD or structure a call spread overwrite into the post-guidance volatility window; the stock is vulnerable to multiple compression, but the business quality limits outright downside unless the next print weakens further.
• Add to UNH on a 1-3 month horizon versus HUM as a relative-value pair; the setup favors insurers with better operating leverage to improving medical cost trends and less policy overhang.
• Take a tactical long in BX versus ARES/KKR on the next 1-2 sessions if redemption fear continues to fade; the bigger platform can absorb sentiment shocks better and should re-rate faster once withdrawal concerns stabilize.
• Avoid chasing PVH weakness; instead, look for a rebound short via put spreads if discretionary spending data deteriorates further, because the market is starting to price in a slower demand backdrop rather than a single-quarter miss.